We have started selling antibodies against the novel coronavirus.

Kyoto Pharmaceutical Co., Ltd. has jointly developed a recombinant rabbit monoclonal antibody against the novel coronavirus (SARS-CoV-2) with Abwiz Bio Inc. (headquartered in California, USA). The developed antibody product will be available for sale starting in December.

Inquiry about this news
Contact Us OnlineMore Details & Registration
Details & Registration
Related Links
Started selling antibodies against the novel coronavirus